**************************************************************

http://groups.yahoo.com/group/aspartameNM/message/1113
The Truth behind the Vaccine Coverup, Russell Blaylock MD:
Murray 2004.09.11 rmforall

[ Comments, corrections of obvious typos, and added spacing for readability
by Rich Murray are in square brackets.

Rich Murray, MA Room For All rmforall@...
1943 Otowi Road, Santa Fe, New Mexico 87505 USA 505-501-2298 ]

http://sydney.indymedia.org/front.php3?article_id=45874&group=webcast

Sydney IMC Wiki Pages | The Sydney IMC is an open publishing website.

The Truth behind the Vaccine Coverup by Russell Blaylock MD
1:53am Thu Sep 9 '04 (Modified on 7:19am Fri Sep 10 '04) article#45874

This information should be shared with as many people as possible, please
help if you can, thanks. Any children that can be saved would be a great
service to humanity.

THE TRUTH BEHIND THE VACCINE COVER-UP
By Russell Blaylock, M.D. (c) 2004 http://www.russellblaylockmd.com

[ Advanced Nutritional Concepts, LLC
Russell L. Blaylock, M.D. PO Box 2670 Ridgeland, MS 39158-2670 ]

Posted: 04 September 2004

I was asked to write a paper on some of the newer mechanisms of vaccine
damage to the nervous system, but in the interim I came across an incredible
document that should blow the lid off the cover-up being engineered by the
pharmaceutical companies in conjunction with powerful governmental agencies.

It all started when a friend of mind sent me a copy of a letter from
Congressman David Weldon, M.D. to the director of the CDC, Dr Julie L.
Gerberding, in which he alludes to a study by a Doctor Thomas Verstraeten,
then representing the CDC, on the connection between infant exposure to
thimerosal-containing vaccines and neurodevelopmental injury.

In this shocking letter, Congressman Weldon refers to Dr. Verstraeten's
study which looked at the data from the Vaccine Safety Datalink and found a
significant correlation between thimerosal exposure via vaccines and several
neurodevelopmental disorders including tics, speech and language delays, and
possibly to ADD.

Congressman Weldon questions the CDC director as to why, following this
meeting, Dr. Verstraeten published his results, almost four years later, in
the journal Pediatrics to show just the opposite, that is, that there was no
correlation to any neurodevelopmental problems related to thimerosal
exposure in infants.

In this letter, Congressman Weldon refers to a report of the minutes of this
meeting held in Georgia, which exposes some incredible statements by the
"experts" making up this study group. The group's purpose was to evaluate
and discuss Dr. Verstraeten's results and data and make recommendation that
would eventually lead to possible alterations in the existing vaccine
policy.

I contacted Congressman Weldon's legislative assistant and he kindly sent me
a complete copy of this report. Now, as usual in these cases, the
government did not give up this report willingly, it required a Freedom of
Information Act lawsuit to pry it loose.
Having read the report twice and carefully analyzed it;
I can see why they did not want any outsiders to see it. It is
a bombshell, as you shall see. In this analysis, I will not only describe
and discuss this report, but also will frequently quote their words directly
and supply the exact page number so others can see for themselves.

The official title of the meeting was the
"Scientific Review of Vaccine Safety Datalink Information."
This conference, held on June 7-8, 2000 at
Simpsonwood Retreat Center, Norcross, Georgia,
assembled 51 scientists and physicians, of which five represented vaccine
manufacturers. These included Smith Kline Beecham, Merck, Wyeth, North
American Vaccine and Aventis Pasteur.

During this conference, these scientists focused on the study of the
Datalink material, whose main author was Dr. Thomas Verstraesten, who
identified himself as working at the National Immunization Program of the
CDC. It was discovered by Congressman Weldon that Dr. Verstraeten left the
CDC shortly after this conference to work for GlaxoSmithKline in Belgium
which manufacturers vaccines, a recurring pattern that has been given the
name a "revolving door". It is also interesting to note that
GlaxoSmithKline was involved in several lawsuits over complications
secondary to their vaccines.

To start off the meeting Dr. Roger Bernier, Associate Director for Science
in the National Immunization Program (CDC), related some pertinent history.
He stated that Congressional action in 1977 required that the FDA review
mercury being used in drugs and biologics (vaccines). In meeting this
order, the FDA called for information from the manufacturers of vaccines and
drugs. He notes that a group of European regulators and manufacturers met
on April 1999 and noted the situation but made no recommendations of
changes. In other words it was all for show.

At this point Dr. Bernier made an incredible statement (page 12). He said,
"In the United States there was a growing recognition that cumulative
exposure may exceed some of the guidelines."
By guidelines, he is referring to guidelines for mercury exposure safety
levels set by several regulatory agencies. The three guidelines were set by
the ATSDR, the FDA and the EPA. The most consistently violated safety
guideline was that set by the EPA. He further explains that he is referring
to children being exposed to thimerosal in vaccines.

Based on this realization that they were violating safety guidelines, he
then says,
"resulted in a joint statement of the Public Health Service (PHS) and the
American Academy of Pediatrics (AAP) in July of last year (1999), which
stated that as a long term goal, it was desirable to remove mercury from
vaccines because it was a potentially preventable source of exposure." (Page
12)

As an aside, one has to wonder, where was the Public Health Service and
American Academy of Pediatrics during all the years of mercury use in
vaccines and why didn't they know that, number one, they were exceeding
regulatory safety levels and second, why weren't they aware of the extensive
literature showing deleterious effects on the developing nervous system of
babies? As we shall see even these "experts" seem to be cloudy on the
mercury literature.

Dr. Bernier notes that in August 1999 a public workshop was held at Bethesda
in the Lister Auditorium by the National Vaccine Advisory Group and the
Interagency Working Group on Vaccines to consider thimerosal risk in vaccine
use. And based on what was discussed in that conference, thimerosal was
removed from the hepatitis B vaccine (HepB). It is interesting to note that
the media took very little interest in what was learned at that meeting and
it may have been a secret meeting as well. As we shall see, there is a
reason why they struggle to keep the contents of all these meetings secret
from the public.

He then notes on page 13 that on October 1999 the Advisory Committee on
Immunization Practices (ACIP),
"looked this situation over again and did not express a preference for any
of the vaccines that were thimerosal free." In this discussion he further
notes that the ACIP concluded that the thimerosal-containing vaccines could
be used but the "long-term goal" is to try to remove thimerosal as soon as
possible.

Now, we need to stop and think about what has transpired here.
We have an important group here;
the ACIP that essentially plays a role in vaccine policy that affects tens of
millions of children every year.
And, we have evidence from the Thimerosal meeting in 1999 that the potential
for serious injury to the infant's brain is so serious that a recommendation
for removal became policy.
In addition, they are all fully aware that tiny babies are receiving mercury
doses that exceed even EPA safety limits,
yet all they can say is that we must,
"try to remove thimerosal as soon as possible".
Do they not worry about the tens of millions of babies that will continue
receiving thimerosal-containing vaccines until they can get around to
stopping the use of thimerosal?

It should also be noted that it is a misnomer to say "removal of thimerosal"
since they are not removing anything. They just plan to stop adding it to
future vaccines once they use up existing stocks, which entails millions of
doses. And, incredibly, the government allows them to do it. Even more
incredibly, the American Academy of Pediatrics and the American Academy of
Family Practice similarly endorse this insane policy. In fact, they
specifically state that children should continue to receive the
thimerosal-containing vaccines until new thimerosal-free vaccine can be
manufactured at the will of the manufacturers. Are they afraid that there
will be a sudden diphtheria epidemic in America or tetanus epidemic?

The most obvious solution was to use only single-dose vials, which requires
no preservative. So, why don't they use them? Oh, they exclaim, it would
add to the cost of the vaccine. Of course, we are only talking about a few
dollars per vaccine at most, certainly worth the health of your child's
brain and future. They could use some of the hundreds of millions of dollars
they waste on vaccine promotion every year to cover these cost for the poor.
Then, that would cut into some fat-cat's budget and we can't have that.

It was disclosed that thimerosal was in all influenza vaccines, DPT (and
most DtaP) vaccines and all HepB vaccines.

As they begin to concentrate on the problem at hand we first begin to learn
that the greatest problem with the meeting is that, they know virtually
nothing about what they are doing. On page 15, for example, they admit that
there is very little pharmacokinetic data on ethylmercury, the form of
mercury in thimerosal. In fact they say there is no data on excretion, the
data on toxicity is sparse, yet it is recognized to cause hypersensitivity,
it can cause neurological problems and even death, and it is known to easily
pass the blood-brain barrier and the placental barrier.

Therefore, what they are admitting is that we have a form of mercury that
has been used in vaccines since the 1930s and no one has bothered to study
the effects on biological systems, especially the brain of infants. Their
defense throughout this conference is "we just don't know the effects of
ethylmercury." As a solution, they resort to studies on methylmercury,
because there are thousands of studies on this form of mercury. The major
source of this form is seafood consumption.

It takes them awhile to get the two forms of mercury straight, since for
several pages of the report they say methylmercury is in thimerosal rather
than ethylmercury. They can be forgiven for this. On page 16, Dr. Johnson,
an immunologist and pediatrician at the University of Colorado School of
Medicine and the National Jewish Center for Immunology and Respiratory
Medicine, notes that he would like to see the incorporation of wide margins
of safety, that is 3 to 10-fold margins of safety to "account for data
uncertainties." What he means is that there are so many things we do not
know about this toxin that we had better use very wide margins of safety.
For most substances the FDA uses a 100-fold margin of safety.

The reason for this, which they do not mention, is that in a society of
hundreds of millions of people there are groups of people who are much more
sensitive to the toxin than others. For instance, the elderly, the
chronically ill, the nutritionally deficient, small babies, premature
babies, those on certain medications and inborn defects in detoxification,
just to name a few. In fact, in this study they excluded premature babies
and low birth weight babies from the main study, some of which had the
highest mercury levels, because they would be hard to study and because they
had the most developmental problems related to the mercury.

On page 16 as well Dr. Johnson make an incredible statement, one that
defines the problem we have in this country with the promoters of these
vaccines. He states,
"As an aside, we found a cultural difference between vaccinologist and
environmental health people in that many of us in the vaccine arena have
never thought about uncertainty factors before. We tend to be relatively
concrete in our thinking."

Then he says,
"One of the big cultural events in that meeting --- was when Dr. Clarkson
repetitively pointed out to us that we just didn't get it about uncertainty,
and he was actually quite right."

This is an incredible admission. First, what is a vaccinologist? Do you go
to school to learn to be one? How many years of residency training are
required to be a vaccinologist? Are there board exams? It's a stupid term
used to describe people who are obsessed with vaccines, not that they
actually study the effects of the vaccines, as we shall see throughout this
meeting. Most important is the admission by Dr. Johnson that he and his
fellow "vaccinologist" are so blinded by their obsession with forcing
vaccines on society that they never even considered
that there might be factors involved that could greatly affect human health,
the so-called "uncertainties." Further, that he and his fellow
"vaccinologist" like to think in concrete terms-- that is, they are very
narrow in their thinking and wear blinders that prevent them from seeing the
numerous problems occurring with large numbers of vaccination in infants and
children. Their goal in life is to vaccinate as many people as possible
with an ever-growing number of vaccines.

On page 17 his "concrete thinking" once again takes over. He refers to the
Bethesda meeting on Thimerosal safety issues and says,
"there was no evidence of a problem, only a theoretical concern that young
infants' developing brains were being exposed to an organomercurial."

Of course, as I shall point out later, it is a lot more than a "theoretical
concern". He then continues by saying,
"We agree that while there was no evidence of a problem the increasing
number of vaccine injections given to infants was increasing the theoretical
mercury exposure risk."

It's hard to conceive of a true scientist not seeing the incredible irony of
these statements. The medical literature is abound with studies on the
deleterious effects of mercury on numerous enzymes, mitochondrial energy
production, synaptic function, dendritic retraction, neurotubule dissolution
and excitotoxicity, yet, he sees only a "theoretical risk" associated with
an ever increasing addition of thimerosal-containing vaccines. It is also
important to note that these geniuses never even saw a problem in the first
place-- it was pressure from outside scientists, parents of affected
children and groups representing them that pointed out the problem. They
were, in essence, reacting to pressure from outside the "vaccinologist club"
and not discovering internally that a problem "might" exist.

In fact, if these outside groups had not become involved these
"vaccinologists" would have continued to add more and more
mercury-containing vaccines to the list of required vaccines. Only when the
problem became so obvious, that is of epidemic proportion (close to that
now) and the legal profession became involved would they have even noticed
there was a problem. This is a recurring theme in the government's
regulatory agencies, as witnessed with fluoride, aspartame, MSG, dioxin and
pesticides issues.

It is also interesting that Dr. Johnson did admit that the greatest risk was
among low birth weight infants and premature infants. Now why would that be
if there existed such a large margin of safety with mercury used in
vaccines? Could just a few pounds of body weight make such a dramatic
difference? In fact, it does but it also means that normal birth weight
children, especially those near the low range of normal birth weight, are
also in greater danger. It also would mean that children receiving doses of
mercury higher than the 72 ug in this study would be at high risk as well
because their dose, based on body weight, would be comparable to that of the
low birth weight child receiving the lower dose. This is never even
considered by these "vaccinologist experts" who decide policy for your
children.

Now this next statement should shock everyone, but especially the poor who
in any way think that these "vaccinologists" experts have their best
interests in mind. Dr. Johnson says on page 17,
"We agree that it would be desirable to remove mercury from U.S. licensed
vaccines, but we did not agree that this was a universal recommendation that
we would make because of the issue concerning preservatives for delivering
vaccines to other countries, particularly developing countries, in the
absence of hard data that implied that there was in fact a problem."

So, here you have it. The data is convincing enough that the American
Academy of Pediatrics and the American Academy of Family Practice, as well
as the regulatory agencies and the CDC along with these organization all
recommend its removal as quickly as possible because of concerns of adverse
effects of mercury on brain development, but not for the children in the
developing countries. I thought the whole idea of child health programs in
the United States directed toward the developing world was to give poor
children a better chance in an increasingly competitive world. This policy
being advocated would increase the neurodevelopmental problems seen in poor
children (also in this country) of developing countries, impairing their
ability to learn and develop competitive minds. Remember, there was a
representative of the World Health Organization (WHO), Dr. John Clements,
serving on this panel of "experts". He never challenged this statement made
by Dr. Johnson.

It also needs to be appreciated that children in developing countries are at
a much greater risk of complications from vaccinations and from mercury
toxicity than children in developed countries. This is because of poor
nutrition, concomitant parasitic and bacterial infections and a high
incidence of low birth weight in these children. We are now witnessing a
disaster in African countries caused by the use of older live virus polio
vaccines that has now produced an epidemic of vaccine related polio, that
is, polio caused by the vaccine itself. In, fact, in some African
countries, polio was not seen until the vaccine was introduced.

The WHO and the "vaccinologist experts" from this country now justify a
continued polio vaccination program with this dangerous vaccine on the basis
that now that they have created the epidemic of polio, they cannot stop the
program. In a recent article it was pointed out that this is the most
deranged reasoning, since more vaccines will mean more vaccine-related cases
of polio. But then, "vaccinologist" have difficulty with these
"uncertainties".
(Jacob JT. A developing country perspective on vaccine-associated paralytic
poliomyelitis. Bulletin WHO 2004; 82: 53-58. See commentary by D.M.
Salisbury at the end of the article.)

Then he again emphasizes the philosophy that the health of children is
secondary to "the program" when he says, "We saw some compelling data that
delaying the birth dose of HepB vaccine would lead to significant disease
burden as a consequence of missed opportunity to immunize." This implies
that our children would be endangered from the risk of hepatitis B should
the vaccine program stop vaccinating newborns with the HepB vaccine.

In fact, this statement is not based on any risk to U.S. children at all and
he makes that plain when he states, "that the potential impact on countries
that have 10% to 15% newborn hepatitis B exposure risk was very distressing
to consider." (page 18) In other words the risk is not to normal U.S.
children but to children in developing countries. In fact, hepatitis B is
not a risk until the teenage years and after in this country. The only
at-risk group among children is with children born to drug using parents;
mothers infected with hepatitis B or HIV infected parents. The reason for
vaccinating the newborns is to capture them before they can escape the
"vaccinologist's" vaccine program.

This is a tactic often used to scare mothers into having their children
vaccinated. For example, they say that if children are not vaccinated
against measles millions of children could die during a measles epidemic.
They know this is nonsense. What they are using is examples taken from
developing countries with poor nutrition and poor immune function in which
such epidemic death can occur. In the United States we would not see this
because of better nutrition, better health facilities and better sanitation.
In fact, most deaths seen when measles outbreaks occur in the United States
occur either in children in which vaccination was contraindicated, the
vaccine did not work or in children with chronic, immune-suppressing
diseases.

In fact, in most studies these children catching the measles or other
childhood diseases have been either fully immunized or partially immunized.
The big secret among "vaccinologists" is that anywhere from 20 to 50% of
children are not resistant to the diseases for which they have been
immunized.

Also on page 18, Dr. Johnson tells the committee that it was Dr. Walt
Orenstein who "asked the most provocative question which introduced a great
deal of discussion. That was, should we try to seek neurodevelopmental
outcomes for children exposed to varying doses of mercury by utilizing the
Vaccine Safety Datalink data from one or more sites." (page 18)

I take from this no one had ever even thought of looking at the data that
had just been sitting there all these years un-reviewed. Children could
have been dropping like flies or suffering from terrible neurodevelopmental
defects caused by the vaccine program and no one in the government would
have known. In fact, that is exactly what the data suggested was happening,
at least as regards neurodevelopmental delays.

We should also appreciate that the government sponsored two conferences on
the possible role of metals, aluminum and mercury, being used in vaccines
without any change in vaccine policy occurring after the meetings. These
meetings were held a year before this meeting and before any examination of
the data which was being held tightly by the CDC, (which was denied to other
independent, highly qualified researchers). I will talk more about what was
discussed in the aluminum conference later. It is very important and is
only briefly referred to in this conference for a very good reason. If the
public knew what was discussed at the aluminum meeting no one would ever get
a vaccination using the presently manufactured types of vaccines again.

Despite what was discussed in the aluminum meeting and the scientific
literature on the neurotoxicity of aluminum, Dr. Johnson makes the following
remark,
"Aluminum salts have a very wide margin of safety. Aluminum and
mercury are often simultaneously administered to infants, both at the same
site and at different sites." Also on page 20, he states, "However, we also
learned that there is absolutely no data, including animal data, about the
potential for synergy, additively or antagonism, all of which can occur in
binary metal mixtures..."

It is important here to appreciate a frequently used deception by those who
are trying to defend an indefensible practice. They use the very same
language just quoted, that is, that there is no data to show, etc, etc.
They intend it to convey the idea that the issue has been looked at and
studied thoroughly and no toxicity was found.
In truth, it means that no one has looked at this possibility and there have
been no studies that would give us an answer one way or the other.

In fact, we know that aluminum is a significant neurotoxin and that it
shares many common mechanisms with mercury as a neurotoxin. For example,
they are both toxic to neuronal neurotubules, interfere with antioxidant
enzymes, poison DNA repair enzymes, interfere with mitochondrial energy
production, block the glutamate reuptake proteins (GLT-1 and GLAST), bind to
DNA, and interfere with neuronal membrane function. Toxins that share toxic
mechanisms are almost always additive and frequently synergistic in their
toxicity. So, Dr. Johnson's statement is sheer nonsense.

A significant number of studies have shown that both of these metals play a
significant role in all of the neurodegenerative disorders. It is also
important to remember, both of these metals accumulate in the brain and
spinal cord. This makes them accumulative toxins and therefore much more
dangerous than rapidly excreted toxins.

To jump ahead, on page 23 Dr. Tom Sinks, Associate Director for Science at
the National Center for Environmental Health at the CDC and the Acting
Division Director for Division of Birth Defects, Developmental Disabilities
and Health, asks,
"I wonder is there a particular health outcome that is related to aluminum
salts that may have anything that we are looking at today?"
Dr. Martin Meyers, Acting Director of the National Vaccine Program Office,
answers,
"No, I don't believe there are any particular health concerns that was
raised."
This is after an aluminum conference held the previous year that did indeed
find significant health concerns and an extensive scientific literature
showing aluminum to be of great concern.

On page 24 Dr. William Weil, a pediatrician representing the Committee on
Environmental Health of the American Academy of Pediatrics, brings some
sense to the discussion by reminding them that,
"there are just a host of neurodevelopmental data that would suggest that
we've got a serious problem. The earlier we go, the more serious the
problem."
Here he means that the further back you go during the child's brain
development, the more likely the damage to the infant. I must give him
credit; at least he briefly
recognized that a significant amount of brain development does take place
later. He also reminds his collogues that aluminum produced severe dementia
and death in dialysis cases. He concludes by saying,
"To think there isn't some possible problem here is unreal." (page 25)

Not to let it end there, Dr. Meyers adds,
"We held the aluminum meeting in conjunction with the metal ions in biology
and medicine meeting-- we were quick to point out that in the absence of
data we didn't know about additive or inhibitory activities."
Once again we see the "no data" ploy. There is abundant data on the
deleterious effects of aluminum on the brain, a significant portion of which
came out in that very meeting.

Dr. Johnson also quotes Dr. Thomas Clarkson, who identifies himself as
associated with the mercury program at the University of Rochester, as
saying that delaying the HepB vaccine for 6 months or so would not affect
the mercury burden. (page 20). He makes the correct conclusion when he
says,
"I would have thought that the difference was in the timing. That is you are
protecting the first six months of the developing central nervous system."

Hallelujah, for a brief moment I thought that they had stumbled on one of
the most basic concepts in neurotoxicology. Then Dr. Meyers dashed my hopes
by saying that single, separated doses would not affect blood levels at all.

At this juncture, we need a little enlightenment. It is important to
appreciate that mercury is a fat soluble metal. That is, it is stored in
the body's fat. The brain contains 60% fat and therefore is a common site
for mercury storage. Now, they establish in this discussion that about half
of methylmercury is excreted over several months when ingested. A recent
study found that ethylmercury has a half-life of 7 days.

Even so, a significant proportion of the mercury will enter the brain (it
has been shown to easily pass through the blood-brain barrier) where it is
stored in the phospholipids (fats). With each new dose, and remember these
children are receiving as many as 22 doses of these vaccines, another
increment is added to the brain storage depot. This is why we call mercury
an accumulative poison. They never once, not once, mention this vital fact
throughout the entire conference. Not once. Moreover, they do so for a
good reason-- it gives the unwary, those not trained in neuroscience,
assurance that all that matters here is blood levels.

In fact, on page 163, Dr. Robert Brent, A developmental biologist and
pediatrician at the Thomas Jefferson University and Dupont Hospital for
Children, says that we don't have data showing accumulation and
"that with the multiple exposures you get an increasing level, and we don't
know whether that is true or not."
He redeems himself somewhat by pointing out that some of the damage is
irreversible and with each dose more irreversible damage occurs and in that
way it is accumulative.

On page 21 Dr. Thomas Clarkson makes the incredible statement implying that
he knows of no studies that shows exposure to mercury after birth or at six
months would have deleterious effects.

Dr. Isabelle Rapin, a neurologist for children at Albert Einstein College of
Medicine, follows up by saying that,
"I am not an expert on mercury in infancy" but she knows it can affect the
nerves (peripheral nervous system).
So, here is one of our experts admitting that she knows little about the
effects of mercury on the infant. My question is--Why is she here?
Dr. Rapin is a neurologist for children at Albert Einstein College of
Medicine who stated that she has a keen interest in developmental disorders,
in particular those involving language and autism, yet she knows little
about the effects on mercury on the infant brain.

This conference is concerned with the effects of mercury in the form of
thimerosal on infant brain development, yet throughout this conference our
experts, especially the "vaccinologists" seem to know little about mercury
except limited literature that shows no toxic effects except at very high
levels. None of the well known experts were invited, such as Dr. Ascher
from Bowman Grey School of Medicine or Dr. Haley Boyd, who has done
extensive work on the toxic effects of low concentrations on the CNS. They
were not invited because they would be harmful to the true objective of this
meeting, and that was to exonerate mercury in vaccines.

Several times throughout this conference, Dr. Brent reminds everyone that
the most sensitive period for the developing brain is during the early
stages of pregnancy. In fact, he pinpoints the 8th to 18th week as the
period of neuromaturation. In fact, the most rapid period of brain
maturation, synaptic development and brain pathway development is during the
last three months of pregnancy continuing until two years after birth. This
is often referred to as the "brain growth spurt." This is also not
mentioned once in this conference -- again because if mothers knew that
their child's brain was busy developing for up to two years after birth they
would be less likely to accept this safety of mercury nonsense these
"vaccinologists" proclaim.

The brain develops over 100 trillion synaptic connections and tens of
trillions of dendritic connections during this highly sensitive period.
Both dendrites and synapses are very sensitive, even to very low doses of
mercury and other toxins. It has also been shown that subtoxic doses of
mercury can block the glutamate transport proteins that play such a vital
role in protecting the brain against excitotoxicity. Compelling studies
indicate that damage to this protective system plays a major role in most of
the neurodegenerative diseases and abnormal brain development as well.

Recent studies have shown that glutamate accumulates in the brains of
autistic children, yet these experts seem to be unconcerned about a
substance (mercury) that is very powerful in triggering brain
excitotoxicity.

It is also interesting to see how many times Dr. Brent emphasizes that we do
not know the threshold for mercury toxicity for the developing brain.
Again, that is not true-- we do know and the Journal of Neurotoxicology
states that anything above 10 ug is neurotoxic. The WHO in fact states that
there is no safe level of mercury.

On page 164 Dr. Robert Davis, Associate Professor of Pediatrics and
Epidemiology at the University of Washington, makes a very important
observation. He points out that in a population like the United States you
have individuals with varying levels of mercury from other causes (diet,
living near coal burning facilities, etc.) and by vaccinating everyone you
raise those with the highest levels even higher and bring those with median
levels into a category of higher levels. The "vaccinologists" with their
problem of "concrete thinking" cannot seem to appreciate the fact that not
everyone is the same. That is, they fail to see these "uncertainties".

To further emphasize this point lets take a farming family who lives within
three miles of a coal-burning electrical plant. Since they also live near
the ocean they eat seafood daily. The fertilizers, pesticides and
herbicides used on the crops contain appreciable levels of mercury. The
coal-burning electrical plant emits high levels of mercury in the air they
breathe daily and the seafood they consume has levels of mercury higher than
EPA safety standards. This means that any babies born to these people will
have very high mercury levels.

Once born, they are given numerous vaccines containing even more mercury,
thereby adding significantly to their already high mercury burden. Are
these "vaccinologists" trying to convince us that these children don't
matter and that they are to be sacrificed at the alter of the "vaccine policy"?

Recent studies by neurotoxicologists have observed that as our ability to
detect subtle toxic effects improves, especially on behavior and other
neurological functions, we lower the level of acceptable exposure. In fact,
Dr, Sinks brings up that exact point, using lead as an example. He notes
that as our neurobehavioral testing improved, we lowered the acceptable dose
considerably and continues to do so. Dr. Johnson had the audacity to add,
"The smarter we get, the lower the threshold."
Yet, neither he, nor the other participants seem to be getting any smarter
concerning this issue.

Dr. Robert Chen, Chief of Vaccine Safety and Development at the National
Immunization Program at the CDC, then reveals why they refuse to act on this
issue, he says,
"the issue is that it is impossible, unethical to leave kids unimmunized, so
you will never, ever resolve that issue. So then we have to refer back from
that." (page 169)
In essence, immunization of the kids takes precedence over safety concerns
with the vaccines themselves. If the problem of vaccine toxicity cannot be
solved, he seems to be saying, then we must accept that some kids will be
harmed by the vaccines.

Dr. Brent makes the statement that he knows of no known genetic
susceptibility data on mercury and therefore assumes there is a fixed
threshold of toxicity. That is, that everyone is susceptible to the same
dose of mercury and there are no genetically hypersensitive groups of
people. In fact, a recent study found just such a genetic susceptibility in
mice. In this study they found that mice susceptible to autoimmunity
developed neurotoxic effects to their hippocampus, including excitotoxicity,
not seen in other strains of mice. They even hypothesize that the same may
be true in humans, since familial autoimmunity increases the likelihood of
autism in offspring. (Hornig M, Chian D, Lipkin WI. Neurotoxic effects of
postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004; (in
press).

For the next quotation you need a little discussion to be able to appreciate
the meaning. They are discussing the fact that in Dr. Verstraeten study
frightening correlations were found between the higher doses of thimerosal
and problems with neurodevelopment, including ADD and autism. The problem
with the study was that there were so few children who had received no
thimerosal-containing vaccines that a true control group could not be used.
Instead they had to use children getting 12.5 ug of mercury as the control
and some even wanted to use the control dose as 37.5 ug. So the controls
had mercury levels that could indeed cause neurodevelopmental problems.
Even with this basic flaw, a strong positive correlation was found between
the dose of mercury given and these neurodevelopmental problems.

It was proposed that they compare a group of children receiving
non-thimerosal vaccines to those who had. In fact, we later lean that they
had a large group of children who could have been used as a thimerosal-free
control. It seems that for two years before this conference the Bethesda
Naval Hospital had been using only thimerosal-free vaccines to immunize the
children. They knew this and I would assume someone would have told Dr.
Verstraeten of this important fact before he did his study.

So, now to the quote. Dr. Braun responds to the idea of starting a new
study using such thimerosal-free controls by saying,
"Sure we will have the answer in five years. The question is what can we do
now with the data we have?" (page 170).
Well, we have the answer to that, they simply covered this study up, declare
that thimerosal is of no concern and continue the unaltered policy. That
is, they can suggest the pharmaceutical manufacturers of vaccines remove the
thimerosal but not making it mandatory or examining the vaccine to make sure
they have removed it.

Lets us take a small peak at just how much we can trust the pharmaceutical
manufacturers to do the right thing. Several reports of major violations of
vaccine manufacturing policy have been cited by the regulatory agencies have
surfaced. This includes obtaining plasma donations without taking adequate
histories on donors as to disease exposures and previous health problems,
poor record keeping on these donors, improper procedures and improper
handing of specimens.

That these are not minor violations is emphasized by the discovery that a
woman with variant Mad Cow Disease was allowed to given plasma to be used in
vaccines in England. In fact, it was learned only after the contaminated
plasma was pooled and used to make millions of doses of vaccines that her
disease was discovered. British health officials told the millions of
vaccinated not to worry, since we have no idea if it will really spread the
disease.

Contamination of vaccines is a major concern in this country as well, as
these regulatory violations make plain. It is also important to note that
no fines were given, just warnings.

Conclusions By The Study Group

At the end of the conference, a poll was taken asking two questions. One
was do you think that there is sufficient data to make a causal connection
between the use of thimerosal-containing vaccines and neurodevelopmental
delays? Second, do you think further study is called for based on this
study?

First, let us see some of the comments on the question of doing further
studies. Dr. Paul Stehr-Green, Associate Professor of Epidemiology at the
University of Washington School of Public Health and Community Medicine, who
voted yes, gave as his reason,
"The implications are so profound these should be examined further." (page
180) Meanwhile, Dr. Brent interjects his concern that the lawyers will get
hold of this information and begin filing lawsuits. He says,
"They want business and this could potentially be a lot of business." (Page
191)

Dr. Loren Koller, Pathologist and Immunotoxicologist at the College of
Veterinary Medicine, Oregon State University, is to be congratulated in that
he recognized that more is involved in the vaccine effects than just
ethylmercury. (page 192) He mentions aluminum and even the viral agents
beings used as other possibilities.

This is especially important in the face of Dr. RK Gherardi's identification
of macrophagic myofascitis, a condition causing profound weakness and
multiple neurological syndromes, one of which closely resembled multiple
sclerosis.

Both human studies and animal studies have shown a strong causal
relationship to the aluminum hydroxide or aluminum phosphate used as a
vaccine adjuvants. More than 200 cases have been identified in European
countries and the United States and has been described as an "emerging
condition".

Here are some of the neurological problems seen with the use of aluminum
hydroxide and aluminum phosphate in vaccines. In two children aged 3 and 5,
doctors at the All Children's Hospital in St. Petersburg, Florida described
chronic intestinal pseudo-obstruction, urinary retention and other findings
indicative of a generalized loss of autonomic nervous system function
(diffuse dysautonomia). The 3-year old had developmental delay and
hypotonia (loss of muscle tone). A biopsy of the children's vaccine
injection site disclosed elevated aluminum levels.

In a study of some 92 patients suffering from this emerging syndrome, eight
developed a full-blown demyelinating CNS disorder (multiple sclerosis).
[Authier FJ, Cherin P, et al. Central nervous system disease in patients
with macrophagic myofasciitis. Brain 2001; 124: 974-983. ] This included
sensory and motor symptoms, visual loss, bladder dysfunction, cerebellar
signs (loss of balance and coordination) and cognitive (thinking) and
behavioral disorders.

Dr. Gherardi, the French physician who first described the condition in
1998, has collected over 200 proven cases. One third of these develop an
autoimmune disease, such as multiple sclerosis. Of critical importance is
his finding that even in the absence of obvious autoimmune disease there is
evidence of chronic immune stimulation caused by the injected aluminum,
known to be a very powerful immune adjuvant.

The reason this is so important is that there is overwhelming evidence that
chronic immune activation in the brain (activation of microglial cells in
the brain) is a major cause of damage in numerous degenerative brain
disorders, from multiple sclerosis to the classic neurodegenerative diseases
(Alzheimer's disease, Parkinson's and ALS). In fact, I have presented
evidence that chronic immune activation of CNS microglia is a major cause of
autism, attention deficit disorder and Gulf War Syndrome.

Dr. Gherardi emphasizes that once the aluminum is injected into the muscle,
the immune activation persists for years. In addition, we must consider the
effect of the aluminum that travels to the brain itself. Numerous studies
have shown harmful effects when aluminum accumulates in the brain. A
growing amount of evidence points to high brain aluminum levels as a major
contributor to Alzheimer's disease and possibly Parkinson's disease and ALS
(Lou Geherig's disease). This may also explain the 10X increase in
Alzheimer's disease in those receiving the flu vaccine 5 years in a row.
(Dr. Hugh Fudenberg, in press, Journal of Clinical Investigation). It is
also interesting to note that a recent study found that aluminum phosphate
produced 3X the blood level of aluminum, as did aluminum hydroxide. (Flarend
RE, Hem SL, et al. In vivo absorption of aluminum-containing vaccine
adjuvants using 26 Al. Vaccine 1997; 15: 1314-1318.)

Of course, in this conference, our illustrious experts tell us that there is
"no data showing an additive or synergistic effect between mercury and
aluminum."

Dr. Rapin expressed her concern over public opinion when this information
eventually gets out. She says (page 197), they are going to be captured by
the public and we had better make sure that
a) "We council them carefully
and b) that we pursue this because of the very important public health and
public implications of the data."
Dr. Johnson adds. "the stakes are very high...".

From this how can one conclude anything than the fact that at least these
scientists were extremely concerned by what was discovered by this study
examining the vaccine safety datalink material? They were obviously
terrified that the information would leak out to the public.

Stamped in bold letters at the top of each page of the study was the
words, "DO NOT COPY OR RELEASE" and "CONFIDENTIAL."

This is not the wording one would expect on a clinical study of vaccine
safety; rather you would expect it on top-secret NSA or CIA files. Why was
this information being secreted? The answer is obvious-- it might endanger
the vaccine program and indict the federal regulatory agencies for ignoring
this danger for so many years. Our society is littered with millions of
children who have been harmed in one degree or another by this vaccine policy.

In addition, let us not forget the millions of parents who have had to watch
helplessly as their children have been destroyed by this devastating vaccine
program.

Dr. Bernier on page 198 says,
"the negative findings need to be pinned down and published."
Why was he so insistent that the "negative findings" be published? Because
he said, "other less responsible parties will treat this as a signal."
By that he means, a signal of a problem with thimerosal-containing vaccines.
From this, I assume he wants a paper that says only that nothing was found
by the study. As we shall see, he gets his wish.

In addition, on page 198, Dr. Rapin notes that a study in California found a
300X increase in autism following the introduction of certain vaccines.
She quickly attributes this to better physician recognition.
Two things are critical to note at this point.
She makes this assertion on better physician recognition without any data at
all -- just her wishful thinking.
If someone pointing out the dangers of vaccines were to do that, she would
scream "junk science."

Second, Dr. Weil on page 207, attacks this reasoning when he says,
"the number of dose related relationships are linear and statistically
significant. You can play with this all you want. They are linear. They
are statistically significant."
In other words, how can you argue with results that show a strong
dose/response relationship between the dose of mercury and
neurodevelopmental outcomes? The higher the mercury levels in the children,
the greater the number of neurological problems.

He continues by saying that the increase in neurobehavioral problems is
probably real. He tells them that he works in a school system with special
education programs and,
"I have to say the number of kids getting help in special education is
growing nationally and state by state at a rate not seen before. So there
is some kind of increase. We can argue about what it is due to." (page 207)

Dr. Johnson seems to be impressed by the findings as well. He says on page
199,
"This association leads me to favor a recommendation that infants up to two
years old not be immunized with thimerosal containing vaccines if suitable
alternative preparations are available."
Incredibly, he quickly adds,
"I do not believe the diagnosis justified compensation in the Vaccine
Compensation Program at this point."
It is interesting to note that one of our experts in attendance is Dr. Vito
Caserta, the Chief Officer for the Vaccine Injury Compensation Program.

At this point Dr. Johnson tells the group of his concerns for his own
grandchild. He says, (page 200)
"Forgive this personal comment, but I got called out at eight o'clock for an
emergency call and my daughter-in-law delivered a son by c-section.
Our first male in the line of the next generation and I do not want that
grandson to get a Thimerosal containing vaccine until we know better what is
going on. It will probably take a long time. In the meantime, and I know
there are probably implications for this internationally, but in the
meanwhile I think I want that grandson to only be given Thimerosal-free
vaccines."

So, we have a scientist sitting on this panel which will eventually make
policy concerning all of the children in this country, as well as other
countries, who is terrified about his new grandson getting a
thimerosal-containing vaccine but he is not concerned enough about your
child to speak out and try to stop this insanity. He allows a cover-up to
take place after this meeting adjourns, and remains silent.

It is also interesting to note that he feels the answers will be a long time
coming, but in the mean time, his grandson will be protected. The American
Academy of Pediatrics, The American Academy of Family Practice, the AMA, CDC
and every other organization will endorse these vaccines and proclaim them
to be safe as spring water, but Dr, Johnson and some of the others will keep
their silence.

It is only during the last day of the conference that we learn that most of
the objections concerning the positive relationship between
thimerosal-containing vaccines and ADD and ADHA were bogus. For example,
Dr. Rapin on page 200 notes that all children in the study were below age 6
and that ADD and ADHD are very difficult to diagnose in pre-schoolers. She
also notes that some children were followed for only a short period.

Dr. Stein adds that in fact the average age for diagnosis of ADHD was 4
years and 1 month. A very difficult diagnosis to make and that the
guidelines published by the American Academy of Pediatrics limits diagnosis
to 6 to 12 year olds. Of course, he was implying that too many were
diagnosed as ADHD. Yet, a recent study found that the famous Denmark study
that led to the announcement by the Institute of Medicine that there was no
relationship between autism and the MMR vaccine, used the same tactic. They
cut off the age of follow-up at age six.

It is known that many cases appear after this age group, especially with ADD
and ADHD. In fact, most learning problems appear as the child is called on
to handle more involved intellectual material. Therefore, the chances are
they failed to diagnose a number of cases by stopping the study too early.

Several of the participants tried to imply that autism was a genetic
disorder and therefore could have nothing to do with vaccines. Dr. Weil put
that to rest with this comment,
"We don't see that kind of genetic change in 30 years."
In other words, how can we suddenly see a 300% increase in a genetically
related disorder over such a short period? It is also known that there are
two forms of autism, one that is apparent at birth and one that develops
later in childhood. The former has not changed in incidence since
statistics have been kept; the other is epidemic.

In one interesting exchange, which ends up being their justification for the
view that mercury is of no danger in children vaccinated with vaccines
containing thimerosal, involves two studies in children born to mothers
consuming high intakes of mercury contaminated fish. One study reported in
the journal Neurotoxicology, examined children living in the Republic of
Seychelles. In this study, they examined the effect of prenatal exposure to
mercury through the mother's consumption of fish high in methylmercury.

A battery of developmental milestone tests were done and no adverse effects
were reported in the study reported by Dr. Clarkson and co-workers, the very
same person in this conference. He never mentions that a follow-up study of
these same children did find a positive correlation between methylmercury
exposure and poor performance on a memory test. In a subsequent study of
children living on the Faroe Islands exposed to methylmercury, researchers
did find impairments of neurodevelopment. This experiment was done by a
scientist from Japan.

Throughout the remainder of this discussion, Dr. Clarkson and others refer
to these two studies. When they are reminded that the Faroe study did find
neurological injury to the children, they counter by saying that this was
prenatal exposure to mercury and not after birth as would be seen with
vaccination. The idea being that prenatally the brain is undergoing neural
formation and development making it more vulnerable. As I have mentioned
this rapid brain growth and development continues for two years after birth
and even at age 6 years the brain is only 80% formed.

Dr. Clarkson keeps referring to the Seychelles study, which demonstrated
that the children reached normal neurodevelopmental milestones as shown by a
number of tests. Dr Weil points out on page 216 that this tells us little
about these children's future brain function. He says,
"I have taken a lot of histories of kids who are in trouble in school. The
history is that developmental milestones were normal or advanced and they
can't read at second grade, they can't write at third grade, they can't do
math in the fourth grade and it has no relationship as far as I can tell to
the history we get of the developmental milestones. So I think this is a
very crude measure of neurodevelopment."

In other words, both of these studies tell us nothing about the actual
development of these children's brain function except that they reached the
most basic of milestones. To put this another way, your child may be able
to stack blocks, recognize shapes and have basic language skills but later
in life they could be significantly impaired when it came to higher math, more
advanced language skills (comprehension) and ability to compete in a very
competitive intellectual environment, like college or advanced schooling.
Their future would be limited to the more mundane and intellectually limited
jobs.

Post-natal brain development, that is from birth to age six or seven,
involves the fine tuning of synaptic connections, dendritic development and
pathway refinement, all of which prepare the brain for more complex
thinking. These brain elements are very sensitive to toxins and excessive
immune stimulation during this period. This is never mentioned in this
conference.

In addition, it must be remembered that the children in these two studies
were exposed only to methylmercury and not the combined neurotoxic effect of
mercury, aluminum and excessive and chronic activation of the brain's immune
system (microgia). This is what makes it so incredible, that several of
these "vaccinologists" and so-called experts would express doubt about the
"biological plausibility" of thimerosal or any vaccine component causing
neurodevelopmental problems. The medical literature is exploding with such
studies. The biological plausibility is very powerful.

Mercury, for example, even in low concentrations, is known to impair energy
production by mitochondrial enzymes. The brain has one of the highest
metabolic rates of any organ and impairment of its energy supply, especially
during development, can have devastating consequences.

In addition, mercury, even in lower concentrations, is known to damage DNA
and impair DNA repair enzymes, which again, plays a vital role in brain
development.

Mercury is known to impair neurotubule stability, even in very low
concentrations. Neurotubules are absolutely essential to normal brain cell
function.

Mercury activates microglial cells, which increases excitotoxicity and brain
free radical production as well as lipid peroxidation, central mechanisms in
brain injury.

In addition, even in doses below that which can cause obvious cell injury,
mercury impairs the glutamate transport system, which in turn triggers
excitotoxicity, a central mechanism in autism and other neurological disorders.
Ironically, aluminum also paralyzes this system.

On page 228, we see another admission that the government has had no
interest in demonstrating the safety of thimerosal-containing vaccines
despite over 2000 articles showing harmful effects of mercury. Here we see
a reference to the fact that the FDA,
"has a wonderful facility in Arkansas with hundreds of thousands of animals"
available for any study needed to supply these answers on safety. The big
question to be asked is -- So, why has the government ignored the need for
research to answer these questions concerning thimerosal safety? You will
recall in the beginning the participants of this conference complained that
there were just so few studies or no studies concerning this "problem."

Again, on page 229 Dr, Brent rails about the lawsuit problem. He tells the
others that he has been involved in three lawsuits related to vaccine
injuries leading to birth defects, and concluded,
"If you want to see junk science, look at those cases...".
He then complains about the type of scientists testifying in these cases. He
adds, "But the fact is those scientist are out there in the United States."
In essence, he labels anyone who opposes the "official policy" on vaccines
as a junk scientist. We have seen in the discussion who the "junk
scientists" really are.

Knowing that what they have found can cause them a great deal of problems he
adds,
"The medical/legal findings in this study, causal or not, are
horrendous...If an allegation was made that a child's neurobehavioral
findings were caused by thimerosal-containing vaccines, you could readily
fins a junk scientist who will support the claim with a reasonable degree of
certainty."
On page 229 he then admits that they are in a bad position because they have
no data for their defense. Now, who are the junk scientists?

Is a "real scientist" one who has no data, just wishful thinking and a
"feeling" that everything will be all right? Are real scientists the ones
who omit recognized experts on the problem in question during a conference
because it might endanger the "program"? Or are they the ones who make
statements that they don't want their grandson to get thimerosal-containing
vaccines until the problem is worked out, but then tell millions of parents
that the vaccines are perfectly safe for their children and grandchildren?

Dr. Meyers on page 231 put it this way,
"My own concern, and a couple of you said it, there is an association
between vaccines and outcomes that worries both parents and pediatricians."
He sites other possible connections to vaccine-related neurobehavioral and
neurodevelopmental problems including the number of vaccines being given,
the types of antigens being used and other vaccine additives.

Dr. Caserta tells the group that he attended the aluminum conference the
previous years and learned that often metals could act differently in
biological systems than as an ion. This is interesting in the face of the
finding that fluoride when combined to aluminum forms a compound that can
destroy numerous hippocampal neurons at a concentration of 0.5 ppm in
drinking water. It seems that aluminum readily combines with fluoride to
form this toxic compound. With over 60% of communities having fluoridated
drinking water this becomes a major concern.

It has also been learned that fluroaluminum compounds mimic the phosphate
compound and can activate G-proteins. G-proteins play a major role in
numerous biological systems, including endocrine, neurotransmitters, and as
cellular second messengers. Some of the glutamate receptors are operated by
a G-protein mechanism.

Over the next ten to fifteen pages, they discuss how to control this
information so that it will not get out and if it does how to control the
damage. On page 248 Dr. Clements has this to say,
"But there is now the point at which the research results have to be
handled, and even if this committee decides that there is no association and
that information gets out, the work has been done and through the freedom of
information that will be taken by others and will be used in other ways
beyond the control of this group. And I am very concerned about that as I
suspect that it is already too late to do anything regardless of any
professional body and what they say."

In other words, he wants this information kept not only from the public but
also from other scientists and pediatricians until they can be properly
counseled. In the next statement he spills the beans as to why he is
determined that no outsider get hold of this damaging information. He says,
"My mandate as I sit here in this group is to make sure at the end of the
day that 100,000,000 are immunized with DTP, Hepatitis B and if possible
Hib, this year, next year and for many years to come, and that will have to
be with thimerosal containing vaccines unless a miracle occurs and an
alternative is found quickly and is tried and found to be safe."

This is one of the most shocking statements I have ever heard. In essence,
he is saying, I don't care if the vaccines are found to be harmful and
destroying the development of children's brains, these vaccines will be
given now and forever. His only concern by his own admission is to protect
the vaccine program even if it is not safe. Dr. Brent refers to this as an,
"eloquent statement."

On page 253, we again see that these scientists have a double standard when
it comes to their children and grandchildren. Dr. Rapin raises the point
about a loss of an IQ point caused by thimerosal exposure. She says, "Can
we measure the IQ that accurately, that this one little point is relevant?"
Then she answers her own question by saying,
"Even in my grandchildren, one IQ point I am going to fight about."
Yet, they are saying in unison, in essence -- TO HELL WITH YOUR CHILDREN --
to the rest of America.

It is also interesting that they bring up the history of lead as a
neurobehavioral toxin. Dr. Weil noted that the neurotoxicologists and
regulatory agencies have lowered the acceptable level from 10 to 5 ug. In
fact, some feel that even lower levels are neurotoxic to the developing
brain. Before the toxicologists began to look at lead as a brain toxin in
children, most "experts" assumed it was not toxic even at very high levels.
Again, it shows that "experts" can be wrong and it is the public who pays
the price.

Dr. Chen on page 256 expresses his concern about this information reaching
the public. He remarks,
"We have been privileged so far that given the sensitivity of information,
we have been able to manage to keep it out of, lets say, less responsible
hands..."
Dr. Bernier agrees and notes, "This information has been held fairly
tightly." Later he calls it,
"embargoed information," and, "very highly protected information."

That they knew the implications of what they had discovered was illustrated
by Dr. Chen's statement on page 258. He says,
"I think overall there was this aura that we were engaged in something as
important as anything else we have ever done. So I think that this was
another element to this that made this a special meeting." You may
remember, Dr. Weil emphasized that the data analysis left no doubt that
there was a strong correlation between neurodevelopmental problems and
exposure to thimerosal-containing vaccines. So if they understood the
importance of this finding and this was the most important thing they have
ever dealt with -- why was this being kept from the public? In fact, it
gets even worse.

Just so you will not doubt my statement that this audience of experts was
not objective, I give you the words of Dr. Walter Orenstein, Director of the
National Immunization Program at the CDC, on page 259.
He tells the group,
"I have seen him (Verstraeten) in audience after audience deal with
exceedingly skeptical individuals..."
"Exceedingly skeptical individuals"-- does that sound like objective
scientists who wanted to look at the data with a clear mind or were they
scientists who were convinced before the meeting was held that there was no
danger to children from thimerosal or any other vaccine component?

In one of the closing remarks by Dr. Bernier (page 257) says,
"the other thing I was struck by was the science,"
meaning the science expressed by the attendees of the meeting.
Then Dr, Orenstein adds,
"I would also like to thank Roger Bernier who pulled off this meeting in
rather short notice..."
Here is a meeting that has been called one of the most important they have
ever dealt with and we learn that it was pulled off on short notice. In
addition, we were told that the results of this meeting would lead to
eventual vaccine policy.

He then has the nerve to add,
"In a sense this meeting addresses some of the concerns we had last summer
when we were trying to make policy in the absence of a careful scientific
review. I think this time we have gotten it straight."

Well, I hate to be the one to break the news, but he didn't get it straight.
There was little or no science in this meeting; rather it was composed of a
lot of haggling and nit picking over epidemiological methodology and
statistical minutia in an effort to discredit the data without success. In
fact, the so-called mercury experts admitted they had to do some quick
homework to refresh their memories and learn something about the subject.

Conclusions

This top secret meeting was held to discuss a study done by Dr. Thomas
Verstraeten and his co-workers using Vaccine Safety Datalink data as a
project collaboration between the CDC's National Immunization Program (NIP)
and four HMOs. The study examined the records of 110,000 children. Within
the limits of the data, they did a very through study and found the
following:

Exposure to thimerosal-containing vaccines at one month was associated
significantly with the misery and unhappiness disorder that was dose
related. That is, the higher the child's exposure to thimerosal the higher
the incidence of the disorder. This disorder is characterized by a baby
that cries uncontrollably and is fretful more so than that see in normal
babies.

Found a nearly significant increased risk of ADD with 12.5ug exposure at one
month.

With exposure at 3 months, they found an increasing risk of
neurodevelopmental disorder with increasing exposure to thimerosal. This
was statistically significant. This included speech disorders.

It is important to remember that the control group was not children without
thimerosal exposure, but rather those at 12.5 ug exposure. This means that
there is a significant likelihood that even more neurodevelopmental problems
would have been seen had they used a real control population.

No one disagreed that these findings were significant and troubling. Yet when
the final study was published in the journal Pediatrics Dr. Verstraeten and
co-workers reported no consistent associations were found between
thimerosal-containing vaccine exposure and neurodevelopmental problems. In
addition, he list himself as an employee of the CDC, not disclosing the fact
that at the time the article was accepted, he worked for GlaxoSmithKline, a
vaccine manufacturing company.

So how did they do this bit of prestidigitation? They simply added another
HMO to the data, the Harvard Pilgrimage. Congressman Dave Weldon noted in
his letter to the CDC Director that this HMO had been in receivership by the
state of Massachusetts because its records were in shambles. Yet, this
study was able to make the embarrassing data from his previous study
disappear.

Attempts by Congressman Weldon to force the CDC to release the data to an
independent researcher, Dr. Mark Geier, a researcher with impeccable
credentials and widely published in peer-reviewed journals, have failed
repeatedly.

It is obvious that a massive cover-up is in progress, as we have seen with
so many other scandals -- fluoride, food-based excitotoxins, pesticides,
aluminum and now vaccines.

I would caution those critical of the present vaccine policy not to put all
their eggs in one basket, that is, with thimerosal as being the main culprit.
There is no question that it plays a major role, but there are other factors
that are also critical, including aluminum, fluoroaluminum complexes, and
chronic immune activation of brain microglia.

In fact, excessive, chronic microglial activation can explain many of the
effects of excessive vaccine exposure as I point out in two recently
published articles. One property of both aluminum and mercury is microglial
activation. With chronic microglial activation large concentrations of
excitotoxins are released as well as neurotoxic cytokines. These have been
shown to destroy synaptic connections, dendrites and cause abnormal pathway
development in the developing brain as well as adult brain.

In essence, too many vaccines are being given to children during the brain's
most rapid growth period. Known toxic metals are beings used in the
vaccines that interfere with brain metabolism, antioxidant enzymes, damage
DNA and DNA repair enzymes and trigger excitotoxicity.

Removing the mercury will help but will not solve the problem because
overactivation of the brain's immune system will cause varying degrees of
neurological damage to the highly-vulnerable developing brain.

References For This Article

Lorscheider,FL; Vimy,MJ; Pendergrass,JC; Haley,BE.
Mercury vapor exposure inhibits tubulin binding to GTP in rat brain: A
molecular lesion also present in human Alzheimer brain From: FASEB J. 1995;
9(4): A-3845. FASEB Annual Meeting, Atlanta, Georgia, 10 March 1995.

Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F,
Keiding N.
Methylmercury exposure biomarkers as indicators of neurotoxicity
in children aged 7 years. From: Am J Epidemiol. 1999 Aug 1; 150(3): 301-5.

Albers JW, Kallenbach LR, Fine LJ, Langolf GD, Wolfe RA, Donofrio PD, Alessi
AG, Stolp-Smith KA, Bromberg MB.
Neurological abnormalities associated with remote occupational elemental
mercury exposure. Ann Neurol. 1988 Nov; 24(5): 651-9.

Aschner M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH.
Metallothionein induction in fetal rat brain and neonatal primary astrocyte
cultures by in utero exposure to elemental mercury vapor (Hg0). From:
Brain Res. 1997 Dec 5; 778(1): 222-32.

Soederstroem S, Fredriksson A, Dencker L & Ebendal T.
The effect of mercury vapour on cholinergic neurons in the fetal brain:
studies on the expression of nerve growth factor and its low- and
high-affinity receptors.
Developmental Brain Research. 1995; 85(1): 96-108.

Drasch G, Schupp I, Hofl H, Reinke R & Roider G.
Mercury burden of human fetal and infant tissues.
Eur J Pediatr. 1994; 153: 607-610.

Szucs A, Angiello C, Salanki J, Carpenter DO.
Effects of inorganic mercury and methylmercury on the ionic currents of
cultured rat hippocampal neurons.
Cell Mol Neurobiol. 1997 Jun; 17(3): 273-88.

Teresa Coccini, Giovanna Randine, Stefano M. Candura, Rossella E. Nappi,
Leon D. Prockop, and Luigi Manzo.
Low-Level Exposure to Methylmercury Modifies Muscarinic Cholinergic Receptor
Binding Characteristics in Rat Brain and Lymphocytes: Physiologic
Implications and New Opportunities in Biologic Monitoring.
Environ Health Perspect. 2000 Jan; 108(1): 29-33.

Sorg O, Schilter B, Honegger P, Monnet-Tschudi F.
Increased vulnerability of neurones and glial cells to low concentrations of
methylmercury in a prooxidant situation.
Acta Neuropathol (Berl). 1998 Dec; 96(6): 621-7.

Liang YX, Sun RK, Sun Y, Chen ZQ, Li LH.
Psychological effects of low exposure to mercury vapor: application of a
computer-administered neurobehavioral evaluation system.
Environ Res. 1993 Feb; 60(2): 320-7.

Sundberg J, Jonsson S, Karlsson MO, Oskarsson A.
Lactational exposure and neonatal kinetics of methylmercury and inorganic
mercury in mice. Toxicol Appl Pharmacol. 1999 Jan 15; 154(2): 160-9.

Inouye M., Murao K., Kajiwara Y.
Behavorial and neuropathological effects of prenatal methyl Mercury exposure
in mice. Neurobehav.Toxicol Teratol. 1985; 7: 227-232.

Koos et al.
Mercury toxicity in pregnant women, fetus and newborn infant.
Am J Obstet and Gynecol. 1976; 126: 390-409.

Khera et al.
Teratogenic and genetic effects of Mercury toxicity.
In: The biochemistry of Mercury in the environment. Nriagu, J.O., Ed.
Amsterdam, Elsevier, 503-18, 1979.

Drasch G, Schupp I, Hofl H, Reinke R, Roider G.
Mercury burden of human fetal and infant tissues.
Eur J Pediatr. 1994 Aug; 153(8): 607-10.

Yoshida M, Yamamura Y, Satoh H.
Distribution of mercury in guinea pig offspring after in utero exposure to
mercury vapor during late gestation. Arch Toxicol. 1986 Apr; 58(4): 225-8.

YuanY, Atchison WD.
Comparative effects of inorganic divalent mercury, methylmercury and
phenylmercury on membrance excitability and synaptic transmission of CA1
neurons in hippocampal slices of the rat.
Neurotoxicology. 1994; 14(2): 403-411.

Desi I, Nagymajtenyi L, Schulz H.
Effect of subchronic mercury exposure on electrocorticogram of rats.
Neurotoxicology. 1996 Fall-Winter;17(3-4): 719-23.

Bucio L, Garcia C, Souza V, Hernandez E, Gonzalez C, Betancourt M,
Gutierrez-Ruiz MC.
Uptake, cellular distribution and DNA damage produced by mercuric chloride.
Mutat Res. 1999 Jan 25; 423(1-2): 65-72.

Hua MS, Huang CC, Yang YJ.
Chronic elemental mercury intoxication: neuropsychological follow-up case
study. Brain Inj. 1996 May; 10(5): 377-84.

Grandjean P, Weihe P, White RF, Debes F.
Cognitive performance of children prenatally exposed to "safe" levels of
methylmercury. Environ Res. 1998 May; 77(2): 165-72.

Hock C, Drasch G, Golombowski S, Muller-Spahn F, Willershausen-Zonnchen
B, Schwarz P, Hock U, Growdon JH, Nitsch RM.
Increased blood mercury levels in patients with Alzheimer's disease.
J Neural Transm 1998; 105(1): 59-68.

Oskarsson A, Palminger Hallen I & Sundberg J.
Exposure to toxic elements via breast milk. Analyst. 1995; 120(3): 765-770.

Wenstrup D, Ehmann WD, Markesbery WR .
Trace element imbalances in isolated subcellular fractions of Alzheimer's
disease brains. Brain Res 1990 Nov 12; 533(1): 125-31.

Basun H, Forssell LG, Wetterberg L, Winblad B.
Metals and trace elements in plasma and cerebrospinal fluid in normal aging
and Alzheimer's disease.
J Neural Transm Park Dis Dement Sect. 1991; 3(4): 231-58.

Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL.
Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain:
similarity to a molecular lesion in Alzheimer diseased brain.
Neurotoxicology. 1997; 18(2): 315-24.

Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF, Meyermann R.
Demonstration of mercury in the human brain and other organs 17 years after
metallic mercury exposure. Clin Neuropathol. 1996 May-Jun; 15(3): 139-44.

Sanfeliu C, Sebastia J, Cristofol R, Rodriguez-Farre E.
Neurotoxicity of organomercurial compounds.
Neurotox Res. 2003; 5(4): 283-305.

el-Fawal HA, Gong Z, Little AR, Evans HL.
Exposure to methylmercury results in serum autoantibodies to neurotypic and
gliotypic proteins. Neurotoxicology. 1996 Summer; 17(2): 531-9.

Faustman EM, Ponce RA, Ou YC, Mendoza MA, Lewandowski T, Kavanagh T.
Investigations of methylmercury-induced alterations in neurogenesis.
Environ Health Perspect. 2002 Oct; 110 Suppl 5: 859-64.

Reading R.
Thimerosal and the occurrence of autism: negative ecological evidence from
Danish population-based data. Child Care Health Dev. 2004 Jan; 30(1): 90-1.

Qvarnstrom J, Lambertsson L, Havarinasab S, Hultman P, Frech W.
Determination of methylmercury, ethylmercury, and inorganic mercury in mouse
tissues, following administration of thimerosal, by species-specific isotope
dilution GC-inductively coupled plasma-MS.
Anal Chem. 2003 Aug 15; 75(16): 4120-4.

Shanker G, Syversen T, Aschner M.
Astrocyte-mediated methylmercury neurotoxicity.
Biol Trace Elem Res. 2003 Oct; 95(1): 1-10.

Zheng W, Aschner M, Ghersi-Egea JF.
Brain barrier systems: a new frontier in metal neurotoxicological research.
Toxicol Appl Pharmacol. 2003 Oct 1; 192(1): 1-11.

Kawase T, Ishikawa I, Orikasa M, Suzuki A.
An assessment of the impact of thimerosal on childhood neurodevelopmental
disorders.
In: Geier DA, Geier MR. J Biochem (Tokyo). 1989 Jul; 106(1): 8-10.

Aluminum enhances the stimulatory effect of NaF on prostaglandin E2
synthesis in a clonal osteoblast-like cell line, MOB 3-4, in vitro.
Pediatr Rehabil. 2003 Apr-Jun; 6(2): 97-102.

Geier MR, Geier DA.
Thimerosal in childhood vaccines, neurodevelopmental disorders, and heart
disease in the United States. J Amer Physc Surg. 2003; 8: 6-11.

Allen JW, Shanker G, Tan KH, Aschner M.
The consequences of methylmercury exposure on interactive functions between
astrocytes and neurons. Neurotoxicology. 23: 755-759, 2002.

Hansen JC, Reske-Nielsen E, et al.
Distribution of dietary mercury in a dog: Quantitation and localization of
total mercury in organs and central nervous system.
Sci Total Environ. 1989; 78: 23-43.

Zanoli P, Cannazza G, Baraldi M.
Prenatal exposure to methyl mercury in rats: focus on changes in kyrenine
pathway. Brain Res Bull. 2001; 55: 235-238.

Olivieri G, Brack C, et al.
Mercury induces cell cytotoxicity and oxidative stress and increases
beta-amyloid secretion and tau phosphorylation in SHY5Y neuroblastoma cells.
J Neurochem. 2000; 74: 231-236.

Juarez BI, Mattinez M, et al.
Methylmercury increases glutamate extracellular levels in frontal cortex of
awake rats. Neurotoxicology and Teratology. 2002; 24: 767-771.

Geier DA, Geier MR.
An assessment of the impact of thimerosal on childhood neurodevelopmental
disorders. Pediatric Rehabil. 2003; 6: 97-102.

Geier DA, Geier MR.
A comparative evaluation of the effects of MMR immunization and mercury
doses from thimerosal-containing childhood vaccines on the population
prevalence of autism. Med Sci Monit. 2004; 10: P133-139.

Baskin DS, Ngo H, Didenko VV.
Thimerosal indices DNA breaks, caspase-3 activation, membrane damage, and
cell death in cultured human neurons and fibroblast.
Toxicol Sci. 2003; 74: 361-368.

Pichichero ME, et al.
Mercury concentrations and metabolism in infants receiving vaccines
containing thimerosal: a descriptive study. Lancet 2002; 360: 1737-1741.

Murata K, Dakeishi M.
Impact of prenatal methylmercury exposure on child neurodevelopment in the
Faroe Islands. Nippon Eiseigaku Zasshi. 2002; 57: 564-570.

Davidson PW, Myers GJ, et al (Clarkson TW-member of panel).
Effects of prenatal and postnatal exposure from fish consumption on
neurodevelopment: outcomes at 66 months of age in the Seychelles Child
Development Study. JAMA. 1998; 280: 701-707.

Palumbo DR, Cox C, et al. (ClarksonTW).
Association between prenatal exposure to methylmercury and cognitive
functioning in Seychellois children: a reanalysis of the McCarthy Scales of
Children's Ability from the main cohort study.
Environ Res. 2000; 84: 81-88.

Hornig M, Chian D, Lipkin WI.
Neurotoxic effects of postnatal thimerosal are mouse strain dependent.
Mol Psychiatry. (In press).

Ueha-Ishibashi T, et al.
Property of thimerosal-induced decrease in cellular content of gluatathione
in rat thymocytes: a flow cytometric study with 5-chloromethylfluorescein.
Toxicol in Vitro. 2004; 18: 563-569.

Ueha-Ishibaschi T, et al.
Effect of thimerosal, a preservative in vaccines, on intracellular Ca+2
concentration of ra cerebellar neurons. Toxicology 2004; 195: 77-84.

Havarinasab S, Lambertsson L, et al.
Dose-response study of thimerosal-induced murine systemic autoimmunity.
Toxicol Appl Pharmacol. 2004; 194: 169-179.

Verstraeten T, Davis RL, DeStefano F, et al.
Safety of thimerosal-containing vaccines: a two-phase study of computerized
health maintenance organization databases. Pediatrics. 2003; 112: 1039-1048.
(This is the published study that was discussed in the conference. Here the
damaging data is erased and the public is told the thimerosal-containing
vaccines are perfectly safe. In this paper Dr. Verstraeten identified
himself as working for the CDC, but in fact he is working for
GlaxoSmithKline. The editors of the journal Pediatrics should have been
willing to disclose this information once it was
brought to their attention, but they would not.).

Aluminum References

Murayama H, Shin RW, Higuchi J, Shibuya S, Muramoto T, Kitamoto T.
Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary
degeneration evidenced by desferrioxamine-assisted chelating autoclave
method. Am J Pathol. 1999 Sep; 155(3): 877-85.

Shin RW, Kruck TP, Murayama H, Kitamoto T.
A novel trivalent cation chelator Feralex dissociates binding of aluminum
and iron associated with hyperphosphorylated tau of Alzheimer's disease.
Brain Res. 2003 Jan. 24; 961(1): 139-46.

Li W, Ma KK, Sun W, Paudel HK.
Phosphorylation sensitizes microtubule-associated protein tau to
Al(3+)-induced aggregation. Neurochem Res. 1998 Dec; 23(12): 1467-76.

Singer SM, Chambers CB, Newfry GA, Norlund MA, Muma NA.
Tau in aluminum-induced neurofibrillary tangles.
Neurotoxicology. 1997; 18(1): 63-76.

Toda S, Yase Y.
Effect of aluminum on iron-induced lipid peroxidation and protein oxidative
modification of mouse brain homogenate.
Biol Trace Elem Res. 1998 Feb; 61(2): 207-17.

Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA.
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in
Alzheimer's disease: a central role for bound transition metals.
J Neurochem. 2000 Jan; 74(1): 270-9.

Xie CX, Yokel RA.
Aluminum facilitation of iron-mediated lipid peroxidation is dependent on
substrate, pH and aluminum and iron concentrations.
Arch Biochem Biophys. 1996 Mar 15; 327(2): 222-6.

Kawase T, Ishikawa I, Orikasa M, Suzuki A.
Aluminum enhances the stimulatory effect of NaF on prostaglandin E2
synthesis in a clonal osteoblast-like cell line, MOB 3-4, in vitro.
J Biochem (Tokyo). 1989 Jul; 106(1): 8-10.

Jope RS.
Modulation of phosphoinositide hydrolysis by NaF and aluminum in rat
cortical slices. J Neurochem. 1988 Dec; 51(6): 1731-6.

Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teitelbaum SL.
Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line
UMR 106-01. Kidney Int. 1989 May; 35(5): 1119-25.

Shainkin-Kestenbaum R, Adler AJ, Berlyne GM, Caruso C.
Effect of aluminium on superoxide dismutase.
Clin Sci (Lond). 1989 Nov; 77(5): 463-6.

Kawase T, Orikasa M, Suzuki A. Aluminofluoride- and epidermal growth
factor-stimulated DNA synthesis in MOB 3-4-F2 cells.
Pharmacol Toxicol. 1991 Nov; 69(5): 330-7.

Gomes MG, Moreira CA, Mill JG, Massaroni L, Oliveira EM, Stefanon I,
Vassallo DV.
Effects of aluminum on the mechanical and electrical activity of the
Langendorff-perfused rat heart.
Braz J Med Biol Res. 1994 Jan; 27(1): 95-100.

Husaini Y, Rai LC, Mallick N.
Impact of aluminium, fluoride and fluoroaluminate complex on ATPase activity
of Nostoc linckia and Chlorella vulgaris. Biometals. 1996 Jul; 9(3): 277-83.

Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teitelbaum SL.
Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line
UMR 106-01. Kidney Int. 1989 May; 35(5): 1119-25.

Lai JC, Lim L, Davison AN.
Effects of Cd2+, Mn2+, and Al3+ on rat brain synaptosomal uptake of
noradrenaline and serotonin.
J Inorg Biochem. 1982 Nov; 17(3): 215-25.

Shainkin-Kestenbaum R, Adler AJ, Berlyne GM, Caruso C.
Effect of aluminium on superoxide dismutase.
Clin Sci (Lond). 1989 Nov; 77(5): 463-6.

Department of Health and Human Services National Vaccine Program Office
Presents: Workshop on Aluminum in Vaccines. Caribe Hilton International
Hotel, San Juan, Puerto Rico: Jointly sponsored by task Force for Child
Survival and Development. May 12, 2000.

Varner JA, Jenson KF, Harvath W, Isaacson RL.
Chronic administration of aliminum-fluoride or sodium-fluoride to rats in
drinking water: alterations in neuronal and cerebrovascular integrity.
Brain Res 784: 284-298, 1998.

Strunecka A, Pataocka J.
Aluminofluoride complexes: new phosphate analogues for laboratory
investigations and potential danger for living organisms.
http://www.fluoridation.com/brain3.htm

Candura SM, Castildi AF, et al.
Interaction of aluminum ions with phosphoinositide metabolism in rat
cerebral cortical membranes. Life Sci. 1991; 49: 1245-1252.

Publicover SJ.
Brief exposure to the G-protein activator NaF/ AlCl3 induces prolonged
enhancement of synaptic transmission in area of rat hippocampal slices.
Expl Brain Res. 1991; 84: 680-684.

Brenner A.
Macrophagic myofascitiitis: a summery of Dr. Gherardi's presentations.
Vaccine. 2002; 20 Supp 3): S5-6, 2002.

Lacson AG, D'Cruz CA, et al.
Aluminum phagocytosis in quadriceps muscle following vaccination in
children: relationship to macrophagic myofasciitis.
Pediatr Dev Pathol. 5: 151-158, 2002.

Flarend RE, Hem SL, et al.
In vivo absorption of aluminum-containing vaccine adjuvants using 26 Al.
Vaccine. 1997 Aug-Sep; 15(12-13): 1314-8.

Authier FJ, Cherin P, et al.
Central nervous system disease in patients with macrophagic myofasciitis.
Brain. 124: 974-983, 2001.

Gherardi RK.
Lessons from macrophagic myofasciitis: towards definition of a vaccine
adjuvant-related syndrome. Rev Neurol (Paris). 159: 162-164, 2003.

Bergfors E, Trollfors B, Inerot A.
Unexpectantly high incidence of persistent itching and delayed
hypersensitivity to aluminum in children after the used of absorbed vaccines
from a single manufacturer. Vaccine. 2003; 22: 64-69.

Deloncle R, Fauconneau B, et al.
Aluminum L-glutamate complexes in rat brain cortex: in vivo prevention of
aluminum deposit by magnesium D-aspartate.
Brain Res. 2002; 946: 247-252.

Mundy WR, Freudenrich TM, Kodavanti PR.
Aluminum potentates glutamate-induced calcium accumulation and iron-induced
oxygen free radical formation in primary neuronal cultures.
Mol Chem Neuropathol. 1997; 32: 41-57.

References Concerning Lead

Naatala JT, Loikkanen JJ, et al.
Lead amplifies glutamate-induced oxidative stress.
Free Radical Biology Medicine. 1995; 19: 689-693.

Morgan RE, Garavan H, et al.
Early lead exposure produces lasting changes in sustained attention,
response initiation, and reactivity to errors.
Neurotoxicology and Teratology. 2001; 23: 519-531.

Needleman HL, McFarland C, et al.
Bone lead levels in adjudicated delinquents: A case control study.
Neurotoxicology and Teratology. 2002; 24: 711-717.

Dietrich KN, Ris MD, et al.
Early exposure to lead and juvenile delinquency.
Neurotoxicology and Teratology. 2001; 23: 511-518.

My References [ not in PubMed ]

Blaylock RL.
Interaction of cytokines, excitotoxins, and reactive nitrogen and oxygen
species in autism spectrum disorders. J. Amer Nutr Assoc. 2003; 6: 21-35.

Blaylock RL.
The central role of excitotoxicity in autism spectrum disorders.
J Amer Nutra Assoc. 2003; 6: 7-19.

Blaylock RL.
Chronic microglial activation and excitotoxicity secondary to excessive
immune stimulation: possible factors in Gulf War Syndrome and autism.
J Amer Phys Surg. 2004; 9: 46-51.
**************************************************************

Internet services by: Solution Oriented Systems, Inc.
www.whno.net/vaccine_coverup.htm Make a quick comment on this article.

add your own longer comments (including web links and multimedia uploads)
Comments may be edited or hidden according to these policy guidelines

Make a rating on this article.
select a rating Uninformative OK Good stuff Recommended Excellent

vaccinations
by cecilia jones 4:03pm Thu Sep 9 '04comment#45909
linddale@...
I agree with the article. I am a mother who refuse the MMR vaccine for my
child. It's amazing how many people support the vaccine without looking at
facts and disagree but i think the article is spot on.

ill pass it to many people as i can
regards cecilia sydney

Well done!
by Father of 6 year old autistic son 7:19am Fri Sep 10 '04comment#45940

An excellent article, and exposes the cover-up going on. I propose criminal
charges be brought against those involved. Our children are the victims.

All material is free for non-profit reuse unless otherwise noted by the
author. All opinions are those of the people contributing to the site;
sydney indymedia doesn't necessarily agree with them.
**************************************************************

http://groups.yahoo.com/group/aspartameNM/message/1090
aspartame, MSG, excitotoxins, NMDA glutamate receptors, multiple sclerosis:
Blaylock: Martini: Murray 2004.06.25 rmforall

http://groups.yahoo.com/group/aspartameNM/message/97
Lancet website aspartame letter 1999.07.29:
Excitotoxins 1999 Part 1/3 Blaylock: Murray 2000.01.14 rmforall
The Medical Sentinel Journal. 1999 Fall; (95 references)
http://www.dorway.com/blayenn.html

http://www.truthinlabeling.org/ Truth in Labeling Campaign [MSG]
Adrienne Samuels, PhD The toxicity/safety of processed
free glutamic acid (MSG): a study in suppression of information.
Accountability in Research 1999; 6: 259-310. 52-page review
P.O. Box 2532 Darien, Illinois 60561
858-481-9333 adandjack@...

Russell L. Blaylock, MD 601-982-1175 Madison, Mississippi
"Excitotoxins: The Taste that Kills", 1977, 298 p., 493 references.
"Health and Nutrition Secrets that can save your life", 2002, 459 p.,
558 + 30 references, $ 30 http://www.russellblaylockmd.com/

George R. Schwartz, MD "In Bad Taste: The MSG Syndrome", 1988
http://www.healthpress.com/ goodbooks@...
PO Box 37470 Albuquerque, NM 87176 505-888-1394
Kathleen Frazier, Publisher
**************************************************************

http://groups.yahoo.com/group/aspartameNM/message/1106
hangover research relevant to toxicity of 11% methanol in aspartame
(formaldehyde, formic acid): Calder I (full text): Jones AW: also some
methanol from fruit pectin in colon: Murray 2004.09.09 rmforall

Rich Murray, MA Room For All rmforall@...
1943 Otowi Road, Santa Fe, New Mexico 87505 USA 505-501-2298

[ NutraSweet, Equal, Canderel, Benevia, E951 ]

Since no adaquate data has ever been published on the exact disposition of
the toxic metabolites, formaldehyde and formic acid, in specific tissues in
humans of the readily released 11% methanol component of aspartame, the many
studies on morning-after hangover from the methanol impurity in alcohol
drinks are the main available resource to date.

http://groups.yahoo.com/group/aspartameNM/message/1100
research on aspartame (methanol, formaldehyde, formic acid) toxicity:
Murray 2004.09.09 rmforall

[ NutraSweet, Equal, Canderel, Benevia, E951 ]

http://groups.yahoo.com/group/aspartameNM/message/927
Donald Rumsfeld, 1977 head of Searle Corp., got aspartame FDA approval:
Turner: Murray 2002.12.23 rmforall

A very detailed, highly credible account of the dubious approval process for
aspartame in July, 1981 is part of the just released two-hour documentary
"Sweet Misery, A Poisoned World: An Industry Case Study of a Food Supply
In Crisis" by Cori Brackett: cori@...
http://www.soundandfuryproductions.com/ 520-624-9710
2301 East Broadway, Suite 111 Tucson, AZ 85719

http://groups.yahoo.com/group/aspartameNM/messages
129 members, 1,113 posts in a public searchable archive

http://groups.yahoo.com/group/aspartame/messages
829 members, 17,325 posts in a public, searchable archive

Poor memory is one of the main early complaints of aspartame reactors, who
are often people who use over 6 cans ( 2 L) diet soda daily for years.

The 6 experimental rats in this recent economical, focused study by
McConnaughey M et al (2004 May), drank a comparable level for 4 months,
about 13% of a 30-month lifespan. It is an excellent introduction to the
main issues.

Only after 3 months did the 6 aspartame rats show almost a doubling of time
to run a single-choice maze.

At 4 months, there was almost another doubling of delay: "...two of the
treated rats even went to the wrong side of the T-maze, totally forgetting
where the reward was." These are very powerful, worrisome results.

There were highly significant, neurologically relevant changes in certain
brain receptor densities, and changes in brain chemistry.

With 70 citations, the relevant scientific literature is well summarized.
Many other studies, often industry funded, often used single doses or
too short durations of exposure, along with lower doses, thus rarely proving
memory deficits.

The funding source for this extremely valuable study is not given.
It used a team of talented high school students.

The fact that certain brain receptor densitities increased, and that memory
deficit increase took 3 months to be significant, may reflect the paradox of
hormesis, the complex ability of organisms to make themselves stronger in
response to low levels of toxins:

http://groups.yahoo.com/group/aspartameNM/message/1055
hormesis: possible benefits of low-level aspartame (methanol, formaldehyde)
use: Calabrese: Soffritti: Murray 2004.03.11 rmforall

The most toxic part of the fragile aspartame molecule is its 11% methanol
component.

It is an open secret, admitted in a number of published studies for three
decades, that methanol is converted within hours by the liver into
formaldehyde and formic acid, both potent, cumulative toxins that affect all
cell types.

Few know that the classic "morning after" hangover from dark wines and
liquors is largely due to formaldehyde and formic acid from methanol
contamination, not the ethanol itself.

The actual disposition of these toxins in the tissues of human aspartame
reactors has never been determined, or, if determined, never publicly
published.

The study should be replicated, using methanol, formaldehyde, and formic
acid to verify if the same results obtain.

If blood and tissue samples have been stored, then the fast, cheap,
automated, highly sensitive Comet assay, often used to prove DNA damage from
formaldehyde, can be used to replicate the results by Yu F. Sakaki (2002),
whose intripid and much published team in Japan has found DNA damage,
testing 8 tissues from single non-lethal doses of aspartame
(near-significant high levels of DNA damage in 5 tissues) and 38 other
additives in groups of just 4 mice:

http://groups.yahoo.com/group/aspartameNM/message/935
Comet assay finds DNA damage from sucralose, cyclamate, saccharin in
mice: Sasaki YF & Tsuda S Aug 2002: Murray 2003.01.01 rmforall
[ Also borderline evidence, in this pilot study of 39 food additives,
using test groups of 4 mice, for DNA damage from for stomach, colon,
liver, bladder, and lung 3 hr after oral dose of 2000 mg/kg aspartame--
a very high dose. Methanol is the only component of aspartame that can lead
to DNA damage. ]

http://groups.yahoo.com/group/aspartameNM/message/1108
faults in 1999 July EPA 468-page formaldehyde profile:
Elzbieta Skrzydlewska PhD, Assc. Prof., Medical U. of Bialystok, Poland,
abstracts -- ethanol, methanol, formaldehyde, formic acid, acetaldehyde,
lipid peroxidation, green tea, aging, Lyme disease:
Murray 2004.08.08 rmforall

http://groups.yahoo.com/group/aspartameNM/message/1088
Murray, full plain text & critique:
chronic aspartame in rats affects memory, brain cholinergic receptors, and
brain chemistry, Christian B, McConnaughey M et al, 2004 May:
2004.06.05 rmforall

Pharmacol Biochem Behav. 2004 May; 78(1): 121-7.
Chronic aspartame affects T-maze performance, brain cholinergic receptors
and Na(+),K(+)-ATPase in rats.
Christian B, McConnaughey K, Bethea E, Brantley S, Coffey A, Hammond L,
Harrell S, Metcalf K, Muehlenbein D, Spruill W, Brinson L, McConnaughey M.
Department of Pharmacology, Brody School of Medicine, East Carolina
University, Greenville, NC 27858, USA;
North Carolina School of Science and Mathematics, Durham, NC 27811.
http://www.ecu.edu/pharmacology/faculty/mcconnaughey.html
Mona M. McConnaughey, Ph.D. Research Assistant Professor
Department: PHARMACOLOGY & TOXICOLOGY
Office: Brody Medical Science 6E-120A 252-744-2756
MCCONNAUGHEYM@...

This study demonstrated that chronic aspartame consumption in rats can lead
to altered T-maze performance and increased muscarinic cholinergic receptor
densities in certain brain regions.
Control and treated rats were trained in a T-maze to a particular side and
then periodically tested to see how well they retained the learned response.
Rats that had received aspartame (250 mg/kg/day) in the drinking water for 3
or 4 months showed a significant increase in time to reach the reward in the
T-maze, suggesting a possible effect on memory due to the artificial
sweetener. Using [(3)H]quinuclidinyl benzilate (QNB) (1 nM) to label
muscarinic cholinergic receptors and atropine (10(-6) M) to determine
nonspecific binding in whole-brain preparations,
aspartame-treated rats showed a 31% increase in receptor numbers when
compared to controls.
In aspartame-treated rats, there was a significant increase in muscarinic
receptor densities in the frontal cortex, midcortex, posterior cortex,
hippocampus, hypothalamus and cerebellum of 80%, 60%, 61%, 65%,
66% and 60%, respectively.
The midbrain was the only area where preparations from aspartame-treated
rats showed a significant increase in Na(+),K(+)-ATPase activity.
It can be concluded from these data that long-term consumption of aspartame
can affect T-maze performance in rats and alter receptor densities or
enzymes in brain. PMID: 15159141

http://groups.yahoo.com/group/aspartameNM/message/1067
eyelid contact dermatitis by formaldehyde from aspartame, AM Hill & DV
Belsito, Nov 2003: Murray 2004.03.30 rmforall [ 150 KB ]

"A 60-year-old Caucasian woman presented with a 6-month history of eyelid
dermatitis...

By strictly avoiding formaldehyde and all formaldehyde releasers for the
next 3 weeks, she improved only slightly.

Her problem, however, was subsequently solved when a local pharmacist
advised her to avoid aspartame.

She had begun using an aspartame-based artificial sweetener 5 months prior
to the onset of her dermatitis. [ 12 months of low-level aspartame use until
stopping. ]

Within 1 week of discontinuing the aspartame, her eyelid dermatitis resolved
completely and has not recurred over 18 months without specific
treatment....

Our patient was consuming an average of 80 mg (1.13 mg/kg) of aspartame
daily, well below the levels previously studied."

[ A packet of tabletop sweetener gives 37 mg aspartame, while a 12 oz diet
soda gives 200 mg aspartame. An aspartame reactor can have immediate strong
symtoms from an under-the-tongue wafer with 4 mg aspartame. ]

http://groups.yahoo.com/group/aspartameNM/message/1039
three-page review: aspartame (methanol, formaldehyde) toxicity:
Murray 2003.11.22 rmforall

http://groups.yahoo.com/group/aspartameNM/message/1026
brief aspartame review: formaldehyde toxicity: Murray 2003.09.11 rmforall

http://groups.yahoo.com/group/aspartameNM/message/1025
aspartame & formaldehyde toxicity: Murray 2003.09.09 rmforall

http://groups.yahoo.com/group/aspartameNM/message/1094
the 11% methanol component of aspartame becomes formaldehyde, now ruled a
carcinogen by WHO International Agency for Research on Cancer: Murray
2004.06.16 rmforall
**************************************************************